que comer con semaglutide Menú de 1 Día Semaglutida y Tirzepatide Consejos de Alimentación con Tirzepatide

The broader category of GLP-1 fatigue affects a significant percentage of users and is worth understanding in detail

and reduced risk of chronic diseases like diabetes and heart disease

Anyone with a BMI of 30 or above, or 27 with at least one weight-related comorbidity, meets the standard prescribing criteria for GLP-1 therapy

However, there are a few red flag symptoms that require professional medical attention

Growth hormone peptides (CJC-1295, ipamorelin, sermorelin) are particularly relevant for this population because endogenous GH production declines approximately 14% per decade after age 30

These symptoms deserve immediate professional assessment to guarantee patient safety